Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
4.030
+0.035 (0.88%)
At close: Feb 6, 2026, 4:00 PM EST
3.945
-0.085 (-2.11%)
After-hours: Feb 6, 2026, 5:05 PM EST
Neuphoria Therapeutics Market Cap
Neuphoria Therapeutics has a market cap or net worth of $21.56 million as of February 6, 2026. Its market cap has increased by 279.69% in one year.
Market Cap
21.56M
Enterprise Value
8.03M
1-Year Change
279.69%
Ranking
Category
Stock Price
$4.03
Market Cap Chart
Since December 24, 2024, Neuphoria Therapeutics's market cap has increased from $10.79M to $21.56M, an increase of 99.86%. That is a compound annual growth rate of 85.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 21.56M | 3.35% |
| Dec 31, 2025 | 20.86M | 273.80% |
| Dec 31, 2024 | 5.58M | -48.27% |
| Dec 24, 2024 | 10.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Boundless Bio | 24.40M |
| Evaxion | 24.27M |
| Palatin Technologies | 24.26M |
| Daré Bioscience | 24.01M |
| IGC Pharma | 23.80M |
| IO Biotech | 23.05M |
| Senti Biosciences | 21.62M |
| Jupiter Neurosciences | 21.20M |